Camille Bedrosian, VP, Chief Medical Officer at Ariad, holds 0.00 shares in Ariad (Ticker: ARIA), holds 35.79K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds ― shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Camille Bedrosian ― shares of Ariad on ― for an estimated value of ―.